Claudia Kedor

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Disease Activity

Placebo Controlled

Rheumatoid Arthritis Patients

Top Venues

Journal of clinical medicine

Annals of the rheumatic diseases

Nature communications

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Paffrath, Laura Kim, Claudia Kedor, Elisa Stein, Rebekka Rust, Helma Freitag, Uta Hoppmann, Leif G Hanitsch, Judith Bellmann-Strobl, Kirsten Wittke, Carmen Scheibenbogen, Franziska Sotzny
Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of clinical medicine 13 (7) (2024)
Anna Paffrath, Laura Kim, Claudia Kedor, Elisa Stein, Rebekka Rust, Helma Freitag, Uta Hoppmann, Leif G Hanitsch, Judith Bellmann-Strobl, Kirsten Wittke, Carmen Scheibenbogen, Franziska Sotzny
Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of clinical medicine 13 (7) (2024)
Laura Froehlich, Jasmin Niedrich, Daniel B R Hattesohl, Uta Behrends, Claudia Kedor, Johannes-Peter Haas, Michael Stingl, Carmen Scheibenbogen
Evaluation of a Webinar to Increase Health Professionals' Knowledge about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Healthcare (Basel, Switzerland) 11 (15) (2023)
Laura Kim, Claudia Kedor, Frank Buttgereit, Harald Heidecke, Desiree Schaumburg, Carmen Scheibenbogen
Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS. Journal of clinical medicine 12 (15) (2023)
Elisa Stein, Cornelia Heindrich, Kirsten Wittke, Claudia Kedor, Laura Kim, Helma Freitag, Anne Krüger, Markus Tölle, Carmen Scheibenbogen
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report. Journal of clinical medicine 12 (19) (2023)
Claudia Kedor, Helma Freitag, Lil Meyer-Arndt, Kirsten Wittke, Leif G Hanitsch, Thomas Zoller, Fridolin Steinbeis, Milan Haffke, Gordon Rudolf, Bettina Heidecker, Thomas Bobbert, Joachim Spranger, Hans-Dieter Volk, Carsten Skurk, Frank Konietschke, Friedemann Paul, Uta Behrends, Judith Bellmann-Strobl, Carmen Scheibenbogen
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature communications 13 (1) (2022)
Lavinia Flaskamp, Constanze Roubal, Steven Uddin, Franziska Sotzny, Claudia Kedor, Sandra Bauer, Carmen Scheibenbogen, Martina Seifert
Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro. Cells 11 (15) (2022)
Joerg Christoph Henes, Sebastian Jonas Saur, David M Kofler, Claudia Kedor, Christoph Meisner, Marion Schuett, Krusche Martin, Ina Koetter, Theodoros Xenitidis, Hendrik Schulze-Koops, Eugen Feist, null null
Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Journal of clinical medicine 11 (18) (2022)
Claudia Kedor, Helma Freitag, Lil Meyer-Arndt, Kirsten Wittke, Leif G Hanitsch, Thomas Zoller, Fridolin Steinbeis, Milan Haffke, Gordon Rudolf, Bettina Heidecker, Thomas Bobbert, Joachim Spranger, Hans-Dieter Volk, Carsten Skurk, Frank Konietschke, Friedemann Paul, Uta Behrends, Judith Bellmann-Strobl, Carmen Scheibenbogen
Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature communications 13 (1) (2022)
Claudia Kedor, Jacqueline Detert, Rolf Rau, Siegfried Wassenberg, Joachim Listing, Pascal Klaus, Tanja Braun, Walter Hermann, Stefan Markus Weiner, Frank Buttgereit, Gerd-Rüdiger R Burmester
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD open 7 (2) (2021)
Khetam Ghannam, Jan Zernicke, Claudia Kedor, Joachim Listing, Gerd-R Burmester, Dirk Foell, Eugen Feist
Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to Canakinumab. Journal of clinical medicine 10 (19) (2021)
Claudia Kedor, Stylianos Tomaras, Daniel Baeumer, Eugen Feist
Update on the therapy of adult-onset Still's disease with a focus on IL-1-inhibition: a systematic review. Therapeutic advances in musculoskeletal disease 13 (2021)
Claudia Kedor, Joachim Listing, Jan Zernicke, Eugen Feist
Response to: 'Changing the outcome measures, changing the results? The urgent need of a specific Disease Activity Score to adult-onset Still's disease' by Ruscitti et al. Annals of the rheumatic diseases (2020)
Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Joerg Christoph Henes, Joern Kekow, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Eva Seipelt, Christof Specker, Eugen Feist
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Annals of the rheumatic diseases 79 (8) (2020)
Claudia Kedor, Jan Zernicke, Eugen Feist
Response to: 'Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'' by Muraviov and Muraviova. Annals of the rheumatic diseases (2020)